Safety study of long-term Omegaven for liver problems from IV nutrition
Part of Blood & lymphatic, Cancer, Hormones & metabolism, Immune system & allergy clinical trials.
This study checks if children who need Omegaven for eight weeks or longer develop a lack of essential fats. It is for kids with liver issues caused by IV nutrition who cannot eat or digest food normally.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is under 18 years old
- Your child has a liver problem from IV nutrition, with a bilirubin level of 2.0 mg/dL or higher
- Your child is expected to need Omegaven for at least eight weeks
- Your child has trouble eating by mouth or has a stomach/intestinal disorder that requires IV nutrition
- Your child has not received Omegaven in the last four weeks
- Your child does not have other serious liver diseases, cirrhosis, or life-threatening conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if SMOFlipid, a special lipid emulsion given through an IV, is safe for children and adults who need most of their nutrition from IV for at least 8 weeks. It looks for side effects like essential fatty acid deficiency or liver problems.
This study tests whether a dietary supplement can affect certain blood markers in healthy children. It will help researchers see if the supplement has any effects on the body.
This trial tests whether giving an omega-3 fat medicine through an IV (along with standard care) improves breathing and blood-flow problems in newborns with congenital diaphragmatic hernia and persistent pulmonary hypertension. It may help reduce strain on the lungs and heart by targeting inflammation and blood-vessel changes.
This study looks at the long-term safety and effects of olipudase alfa in children under 2 years old with acid sphingomyelinase deficiency (ASMD), a rare genetic condition. It aims to see how the treatment works over time and if it is safe for young children.
This study looks at how special nutrition therapy helps young children with chronic liver disease and severe malnutrition. Researchers will measure specific blood markers to see if the treatment improves your child's nutrition and liver function.
This trial tests whether omega-3 fatty acids can help prevent acute graft-versus-host disease (aGVHD) in people receiving a stem cell transplant from a donor. Omega-3 may reduce inflammation and lower the chance of this serious complication.
Hear when a new Malnutrition trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.